Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos


Data from a genetics-based study show PCSK9 inhibition does not affect cognition function or dementia risk; however, statin use may be associated with some impaired cognitive performance that is outweighed by any CV benefits.“PCSK9 inhibition, as modeled via genetic Mendelian randomization methods, has a neutral cognitive profile,” Falk W. Lohoff, MD, chief of the section on clinical